Expression of the two mutants considerably decreased the catalytic palmitoylation activity of ZDHHC20 and inhibited the proliferation and invasion of pancreatic cancer cells (Figs. 3M, 3N, S5J and S5K). Here, ZDHHC20 is linked to familial pancreatic carcinoma.